Abstract
To investigate the in vitro and in vivo activity of imipenem-colistin combination against multidrug-resistant Enterobacter cloacae infections in order to determine whether it should be explored further. The antimicrobial activity of colistin alone and in combination with imipenem was assessed versus an imipenem-susceptible isolate, E. cloacae GN1059, or an imipenem-resistant strain, E. cloacae GN0791, isolated in Anhui, China. The potential synergy of imipenem-colistin was evaluated using a checkerboard assay, as well as static time-kill experiments at 1× and 2× minimum inhibitory concentration (MIC). A simple invertebrate model (Galleria mellonella) was developed to assess the in vivo efficacy of imipenem-colistin in treating E. cloacae infection. In checkerboard assays, synergy (defined as a fractional inhibitory concentration index of ≤ 0.5) was observed between imipenem and colistin for both isolates tested. In time-kill assays, the combination of imipenem-colistin at 1× or 2× MIC resulted in complete killing of both strains. In the G. mellonella larvae model infected with lethal doses of E. cloacae, the combination therapy led to significantly increased survival of the larvae as compared with imipenem or colistin monothera...Continue Reading
References
Feb 2, 2008·The Journal of Antimicrobial Chemotherapy·Miruna D David, Martin J Gill
Jul 18, 2008·The Journal of Hospital Infection·M DalbenS F Costa
Apr 1, 2009·Antimicrobial Agents and Chemotherapy·Anton Y PelegEleftherios Mylonakis
Apr 14, 2009·Diagnostic Microbiology and Infectious Disease·Young Kyoung ParkKwan Soo Ko
Oct 16, 2009·Journal of Clinical Microbiology·Alexandros IkonomidisSpyros Pournaras
Oct 29, 2009·The Journal of Antimicrobial Chemotherapy·K E N Milne, I M Gould
Aug 7, 2010·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Kuan-Hung LinWen-Liang Yu
Sep 17, 2010·Journal of Clinical Microbiology·M TatoR Cantón
Mar 1, 2011·International Journal of Antimicrobial Agents·Hao-Yuan LeeCheng-Hsun Chiu
Dec 22, 2011·Virulence·Michail S Lionakis
Apr 12, 2012·Antimicrobial Agents and Chemotherapy·Michael HornseyDavid W Wareham
Jul 26, 2012·Future Microbiology·Maria Lina MezzatestaStefania Stefani
Feb 21, 2013·Antimicrobial Agents and Chemotherapy·Jessica A O'HaraYohei Doi
Jul 10, 2013·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Hsieh-Shong LeuChing-Tai Huang
Apr 2, 2014·Antimicrobial Agents and Chemotherapy·Jonathan W BettsDavid W Wareham
May 2, 2014·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·J W BettsD W Wareham
Jul 26, 2014·International Journal of Antimicrobial Agents·Vladimir A AgeevetsSergei V Sidorenko
Aug 6, 2014·The Pediatric Infectious Disease Journal·Pia S PannarajScott J Weissman
Aug 15, 2014·Journal of Infection in Developing Countries·Zijuan JianWanchan Peng
Aug 21, 2014·The Journal of Antimicrobial Chemotherapy·Wen-Shyang HsiehHsueh-Hsia Wu
Aug 26, 2014·Emerging Infectious Diseases·Lee M KiedrowskiRobert A Bonomo
Citations
Apr 4, 2017·Expert Opinion on Biological Therapy·Josep M SierraMiguel Viñas
Feb 15, 2019·Frontiers in Microbiology·Chau-Chyun SheuPo-Ren Hsueh
Apr 17, 2019·Frontiers in Microbiology·Mansura S MulaniKarishma R Pardesi
May 31, 2019·Virulence·Marco Alfio CutuliRoberto Di Marco
Apr 25, 2019·Pathogens·Flávia Roberta BrustAlexandre José Macedo
Apr 13, 2017·Frontiers in Cellular and Infection Microbiology·James P DaltonSiouxsie Wiles
Sep 23, 2020·Pathogens and Disease·Monalessa Fábia PereiraDenise Mara Soares Bazzolli
Feb 6, 2021·Pathogens·Gustavo Henrique Rodrigues Vale de MacedoLuís Cláudio Nascimento da Silva
Feb 24, 2021·Antimicrobial Agents and Chemotherapy·Charles OmolloDigby F Warner
Feb 19, 2020·Microbial Pathogenesis·Luciana A LogesAlexandre J Macedo